Jove
Visualize
Contáctanos
JoVE
x logofacebook logolinkedin logoyoutube logo
ACERCA DE JoVE
Visión GeneralLiderazgoBlogCentro de Ayuda JoVE
AUTORES
Proceso de PublicaciónConsejo EditorialAlcance y PolíticasRevisión por ParesPreguntas FrecuentesEnviar
BIBLIOTECARIOS
TestimoniosSuscripcionesAccesoRecursosConsejo Asesor de BibliotecasPreguntas Frecuentes
INVESTIGACIÓN
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchivo
EDUCACIÓN
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualCentro de Recursos para ProfesoresSitio de Profesores
Términos y Condiciones de Uso
Política de Privacidad
Políticas

Videos de Conceptos Relacionados

Disorders of Erythrocytes01:27

Disorders of Erythrocytes

2.0K
Disorders of erythrocytes, or red blood cells (RBCs), include a range of conditions affecting their number, shape, or function.
Erythrocyte disorders can be broadly categorized into two main types: anemic and polycythemic conditions.
A low oxygen-carrying capacity of the blood due to the loss, lower production, or destruction of erythrocytes is termed anemia. Hemorrhagic anemia, for example, occurs when bleeding from an external wound or internal ulcer reduces erythrocyte counts.
On the other...
2.0K
Factors Affecting Erythropoiesis01:24

Factors Affecting Erythropoiesis

5.4K
The cardiovascular system regulates the number of erythrocytes in the bloodstream to ensure optimal oxygen transport. It also prevents over-proliferation of these cells, which helps to maintain blood viscosity and flow rate.
Several factors influence the erythrocyte production rate, with tissue oxygen level being among the most critical. Intense exercise or high altitudes can cause tissue hypoxia, which triggers the kidneys to release more erythropoietin (EPO) into the bloodstream.
EPO then...
5.4K
The Periodic Table and Organismal Elements00:57

The Periodic Table and Organismal Elements

199.4K
Overview
199.4K
Erythropoiesis01:14

Erythropoiesis

5.7K
Red blood cells  (RBCs) transport oxygen to all body tissues. These cells survive only for 120 days and then need to be replenished. Erythropoiesis is the process of RBC production. In healthy individuals, erythropoiesis ensures all tissues are amply supplied with oxygen. In addition, blood loss due to injury leads to a drop in the physiological oxygen level that will cause erythropoiesis. Any defect in erythropoiesis leads to several physiological disorders, including thalassemia, anemia,...
5.7K
The Early Endosome: Endocytosis of Transferrin01:28

The Early Endosome: Endocytosis of Transferrin

4.7K
Essential proteins such as insulin or low-density lipoprotein (LDL) and micronutrients such as iron enter a eukaryotic cell through receptor-mediated endocytosis. Subsequently, the early endosomes fuse with the vesicles containing such receptor-ligand complexes and play a vital role in sorting the incoming ligands and receptors. While the ligands are either degraded inside the vesicle or released into the cytosol, their receptors are returned to the plasma membrane for further rounds of...
4.7K
Vitamins01:30

Vitamins

2.3K
Vitamins, derived from the Latin word for life, are essential organic substances required in small quantities for optimal growth and overall well-being. Unlike other organic nutrients, vitamins don't act as sources of energy or building materials but rather facilitate these nutrients' utilization by the body. Vitamins are predominantly coenzymes, assisting enzymes in specific chemical actions, like the oxidation of glucose for energy involving B vitamins. Most vitamins are not produced...
2.3K

También podría leer

Artículos Relacionados

Artículos vinculados a este trabajo por autores compartidos, revista y gráfico de citas.

Ordenar por
Same author

How Would You Manage This Patient With Iron Deficiency Anemia? Grand Rounds Discussion From Beth Israel Deaconess Medical Center.

Annals of internal medicine·2026
Same author

Efficacy of Single-Dose Intravenous Ferric Derisomaltose for Iron Deficiency Anemia in Pregnancy.

American journal of hematology·2026
Same author

The AABB and ICTMG issued recommendations on the restrictive use of platelet transfusions.

Annals of internal medicine·2025
Same author

Women, Iron, and Altitude-Path to the Peak.

Wilderness & environmental medicine·2025
Same author

10, 14, 19 Essentials?

Wilderness & environmental medicine·2025
Same author

Advancements in complement inhibition for PNH and primary complement-mediated thrombotic microangiopathy.

Blood advances·2025
Same journal

Correction to I.M. Matters News: Sleep medicine for seniors.

Annals of internal medicine·2026
Same journal

Adverse Events After Same-Day COVID-19 and Influenza Vaccination Versus Influenza Vaccination Alone : A Target Trial Emulation.

Annals of internal medicine·2026
Same journal

Leveraging Real-World Evidence to Inform Regulatory, Clinical, and Coverage Decisions Related to Glucagon-Like Peptide-1-Based Therapies: Synopsis of a National Institute of Diabetes and Digestive and Kidney Diseases Workshop.

Annals of internal medicine·2026
Same journal

Methodological Approaches to Real-World Evidence Generation for Glucagon-like Peptide-1-Based Therapies: Synopsis of a National Institute of Diabetes and Digestive and Kidney Diseases Workshop.

Annals of internal medicine·2026
Same journal

Weekly and Biweekly Treatment With Bofanglutide Versus Semaglutide in Chinese Patients With Type 2 Diabetes : A Phase 2b Randomized Clinical Trial.

Annals of internal medicine·2026
Same journal

Grappling with GLP-1 prescribing.

Annals of internal medicine·2026
Ver todos los artículos relacionados

Video Experimental Relacionado

Updated: Jan 14, 2026

Author Spotlight: Developing a Point-of-Care Hemoglobin Estimation Method for Anemia Management
05:35

Author Spotlight: Developing a Point-of-Care Hemoglobin Estimation Method for Anemia Management

Published on: January 19, 2024

1.3K

Anemia por Deficiencia de Hierro

Kylee L Martens1, Thomas G DeLoughery1

  • 1Division of Hematology and Medical Oncology, Oregon Health & Science University, Portland, Oregon (K.L.M., T.G.D.).

Annals of internal medicine
|January 12, 2026
PubMed
Resumen
Este resumen es generado por máquina.

La anemia por deficiencia de hierro (ADH) es una afección común causada por una cantidad insuficiente de hierro. El diagnóstico y tratamiento oportunos, incluida la reposición de hierro, son cruciales para prevenir y controlar la ADH en poblaciones en riesgo.

Palabras clave:
Anemia por deficiencia de hierroDiagnóstico de la anemiaTratamiento de la anemiaReposición de hierroPoblaciones en riesgo

Más Videos Relacionados

Measurement of Tissue Non-Heme Iron Content using a Bathophenanthroline-Based Colorimetric Assay
05:08

Measurement of Tissue Non-Heme Iron Content using a Bathophenanthroline-Based Colorimetric Assay

Published on: January 31, 2022

5.5K
Quantitating Iron Transport Across the Mouse Placenta In Vivo Using Nonradioactive Iron Isotopes
08:45

Quantitating Iron Transport Across the Mouse Placenta In Vivo Using Nonradioactive Iron Isotopes

Published on: May 10, 2022

2.3K

Videos de Experimentos Relacionados

Last Updated: Jan 14, 2026

Author Spotlight: Developing a Point-of-Care Hemoglobin Estimation Method for Anemia Management
05:35

Author Spotlight: Developing a Point-of-Care Hemoglobin Estimation Method for Anemia Management

Published on: January 19, 2024

1.3K
Measurement of Tissue Non-Heme Iron Content using a Bathophenanthroline-Based Colorimetric Assay
05:08

Measurement of Tissue Non-Heme Iron Content using a Bathophenanthroline-Based Colorimetric Assay

Published on: January 31, 2022

5.5K
Quantitating Iron Transport Across the Mouse Placenta In Vivo Using Nonradioactive Iron Isotopes
08:45

Quantitating Iron Transport Across the Mouse Placenta In Vivo Using Nonradioactive Iron Isotopes

Published on: May 10, 2022

2.3K

Área de la Ciencia:

  • Hematología
  • Medicina Clínica
  • Ciencia de la Nutrición

Sus antecedentes:

  • La anemia por deficiencia de hierro (ADH) es una afección clínica prevalente y frecuentemente subdiagnosticada.
  • Los grupos demográficos clave en riesgo incluyen poblaciones pediátricas, embarazadas y de bajos ingresos socioeconómicos.
  • El manejo eficaz depende de la detección temprana y la solución de la causa subyacente de la deficiencia de hierro.

Objetivo del estudio:

  • Resumir las estrategias de diagnóstico y manejo de la anemia por deficiencia de hierro.
  • Destacar las poblaciones con mayor riesgo de ADH.
  • Diferenciar la ADH de otras anemias y guiar el tratamiento.

Principales métodos:

  • Revisión de guías clínicas y literatura sobre anemia por deficiencia de hierro.
  • Análisis de marcadores diagnósticos como la morfología de los glóbulos rojos y el recuento de reticulocitos.
  • Evaluación de intervenciones terapéuticas, incluidas las indicaciones de hierro oral/parenteral y transfusión de sangre.

Principales resultados:

  • El diagnóstico y manejo oportunos son esenciales para prevenir la ADH.
  • La reposición de hierro por vía oral o parenteral es el tratamiento principal.
  • Las transfusiones de sangre se reservan para casos graves específicos junto con la terapia de hierro.

Conclusiones:

  • La ADH requiere un enfoque integral que incluya un diagnóstico preciso, la identificación de las causas subyacentes y la reposición adecuada de hierro.
  • La anemia persistente a pesar de la reposición de hierro requiere la investigación de causas alternativas.
  • La comprensión de los grupos en riesgo y la intervención oportuna son fundamentales para obtener resultados óptimos para el paciente.